Czechia· CZ-0167033

REPAGLINIDE KRKA

A repaglinide product containing repaglinide, registered in Czechia by Krka, d.d., Novo mesto, Novo mesto. The same ATC class is registered in 19 of our 19 countries.

ATC A10BX02

Checked against SÚKL (Czech Republic) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about repaglinideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Repaglinide is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BX02 (repaglinide), each read from that country’s own register.

This record: Czechia, from SÚKL (Czech Republic)
11 of them publish a price we can compare per daily dose

Search repaglinide products by name

Repaglinide · ATC A10BX02

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of repaglinide costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.30 in France to $1.47 in Switzerland — a ×4.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Repaglinide · price per daily dose (4 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.47
IT Italy$0.39
FR France$0.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)

Active substance: REPAGLINIDE
Manufacturer: Krka, d.d., Novo mesto, Novo mesto
Country: Czechia (CZ)
ATC code: A10BX02
ATC class: Repaglinide
Defined daily dose: 4 mg, O
Reimbursed: Not published by this register
Source register: SÚKL (Czech Republic)
Last checked: September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

708 interactions on record for repaglinide.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check repaglinide against other medicines How interaction checks work

Repaglinide · interactions on record

708 records

18 severe
502 moderate
41 minor
145 info

Most severe, free to view

ClopidogrelB01AC04severe
GemfibrozilC10AB04severe
ClotrimazoleA01AB18moderate
CimetidineA02BA01moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Repaglinide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All repaglinide products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
Belgium · Repaglinide Eg
Bulgaria · Индорин
Cyprus · Theroflan
Germany · Repaglinid 1 A Pharma, Repaglinid Abz
Denmark · Repaglinid Doc Generici
Spain · Repaglinida Alter, Repaglinida Aurovitas
Finland · Repaglinid Stada
France · Repaglinide Arrow Lab, Repaglinide Biogaran
United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
Greece · Theroflan
Croatia · Reglinid, Repaglinid Pharmas
Iceland · Enyglid, Novonorm
Italy · Glicam, Repaglinide Aurobindo
Liechtenstein · Repaglinide Teva
Luxembourg · Repaglinide Eg
Latvia · Repaglinide Elvim
Malta · Repaglinide Aurobindo
Netherlands · Repaglinide Stada
Norway · Enyglid, Novonorm
Romania · Reneos, Repaglinida Arena
Sweden · Repaglinid Actavis, Repaglinid Stada
Slovenia · Repaglinid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a85feb9a-2621-410c-842e-59ca62183c63
GET /v1/drugs/a85feb9a-2621-410c-842e-59ca62183c63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "2MG",
  "pack_size": "90",
  "substance": "REPAGLINIDE",
  "cz_kod_sukl": "0167033",
  "product_type": "CH",
  "substance_codes": "11176",
  "registration_state": "R",
  "registration_number": "EU/1/09/579/015"
}

API reference MCP server Plans

See everything about repaglinide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console